New Key Statistics Module, Z-Score and F-Score
WBO:MRSA Key Ratios
Market Cap € M | 24,973.27 |
Enterprise Value € M | 34,736.87 |
P/E(ttm) | 7.92 |
PE Ratio without NRI | 7.92 |
Forward PE Ratio | 16.39 |
Price/Book | 0.52 |
Price/Sales | 0.55 |
Price/Free Cash Flow | 8.58 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.33 |
Revenue (TTM) € M | 48,198.00 |
EPS (TTM) € | 210.30 |
Beneish M-Score | -0.83 |
10-y EBITDA Growth Rate % | 12.90 |
5-y EBITDA Growth Rate % | 45.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.32 |
EV-to-EBITDA | -1.32 |
PEG | 0.17 |
Shares Outstanding M | 15.75 |
Net Margin (%) | 6.75 |
Operating Margin % | -59.43 |
Pre-tax Margin (%) | 7.77 |
Quick Ratio | 2.41 |
Current Ratio | 2.53 |
ROA % (ttm) | 4.28 |
ROE % (ttm) | 6.57 |
ROIC % (ttm) | -39.90 |
Dividend Yield % | 4.42 |
Altman Z-Score | 2.54 |
WBO:MRSA Number of Guru Trades
WBO:MRSA Volume of Guru Trades
Gurus Latest Trades with WBO:MRSA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WBO:MRSA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data